Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Astra Drug Improves Survival by Half in Early Stage Lung Cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Ring, Suzi (AUTHOR)
  • المصدر:
    Bloomberg.com. 6/4/2023, pN.PAG-N.PAG. 1p.
  • معلومة اضافية
    • الموضوع:
      ASTRAZENECA PLC; LUNG cancer; TUMOR classification; NON-small-cell lung carcinoma; DRUGS
    • نبذة مختصرة :
      This data is important because it's "bringing a precision medicine into an early stage of lung cancer." (Bloomberg) -- A blockbuster lung cancer drug from AstraZeneca Plc was found to improve survival by more than half in a subset of patients, boosting the company's ambitions to widen its oncology portfolio across as many groups and indications as possible. [Extracted from the article]
    • نبذة مختصرة :
      Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)